Pembrolizumab in HER2-Positive Gastric Cancer

The addition of pembrolizumab to trastuzumab and chemotherapy in patients with gastric cancer improved both progression-free and overall survival as compared with trastuzumab and chemotherapy alone.

​   The New England Journal of Medicine: Search Results in Gastroenterology